Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Basic Sciences

Isolation and Characterization of Casein-producing and -nonproducing Cell Populations from 7,12-Dimethylbenz(a)anthracene-induced Rat Mammary Carcinomas

Mark L. Johnson, Joseph Levy and Jeffrey M. Rosen
Mark L. Johnson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Levy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey M. Rosen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 1983
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Previous studies from our laboratory have demonstrated that hormone-dependent 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas possess only a limited ability to synthesize the mammary gland-specific milk proteins, and this expression of normal differentiated function is limited to a small subpopulation of tumor cells (S. C. Supowit and J. M. Rosen, Cancer Res., 42: 1355–1360, 1982). In an effort to define the molecular defect in hormone-regulated casein gene expression in these tumors, a method has been developed which separates the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma into two subpopulations of cells. Collagenase-dissociated tumor cell suspensions were fractionated by both continuous and discontinuous Percoll gradient centrifugation, and the separated cell populations were analyzed following plating on collagen-coated dishes. Two fractions of differing densities were isolated. The top fraction (ρ = 1.05), containing approximately 75% of the dissociated tumor epithelial cells, is depleted in casein-producing cells, while the bottom fraction (ρ = 1.07) is enriched 5- to 10-fold in casein-producing cells as assayed by both indirect immunofluorescence, using a specific anticasein antibody, and direct measurement of casein messenger RNA levels. These two subpopulations were further characterized by scanning and transmission electron microscopy, with respect to their cell morphology and ultrastructure, for the presence of hormone receptors; the arrangement of the epithelial cell marker, keratin; and their cell cycle distributions and ploidy. Prolactin, insulin, and estradiol binding were found to be uniform throughout each cell subpopulation and qualitatively similar between fractions. Both fractions appeared to be epithelial-like in morphology, containing numerous surface microvilli as assessed by scanning electron microscopy and contained keratin filaments as determined by indirect immunofluorescence. Furthermore, they had similar cell cycle distributions and ploidies of 2n. Differences in cell ultrastructure were observed between these two tumor epithelial cell fractions, reflecting an increased development of rough endoplasmic reticulum in the bottom fraction and a higher concentration of lipid-containing veiscles and free polysomes in the top fraction. The failure of the majority of the cells within the 7,12-dimethylbenz(a)anthracene-induced mammary tumors to produce casein in response to prolactin is not due to a receptor-negative phenotype or general cell type difference.

Footnotes

  • ↵1 This work was supported by NIH Grant CA 16303.

  • ↵2 Recipient of NIH Fellowship HD 06157.

  • ↵3 To whom all requests for reprints should be addressed.

  • Received September 3, 1982.
  • Accepted January 26, 1983.
  • ©1983 American Association for Cancer Research.
PreviousNext
Back to top
May 1983
Volume 43, Issue 5
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Isolation and Characterization of Casein-producing and -nonproducing Cell Populations from 7,12-Dimethylbenz(a)anthracene-induced Rat Mammary Carcinomas
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Isolation and Characterization of Casein-producing and -nonproducing Cell Populations from 7,12-Dimethylbenz(a)anthracene-induced Rat Mammary Carcinomas
Mark L. Johnson, Joseph Levy and Jeffrey M. Rosen
Cancer Res May 1 1983 (43) (5) 2199-2209;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Isolation and Characterization of Casein-producing and -nonproducing Cell Populations from 7,12-Dimethylbenz(a)anthracene-induced Rat Mammary Carcinomas
Mark L. Johnson, Joseph Levy and Jeffrey M. Rosen
Cancer Res May 1 1983 (43) (5) 2199-2209;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Basic Sciences

  • Down-regulation by Interleukin 4 of Activation of Human Alveolar Macrophages to the Tumoricidal State
  • Allelic Loss on Chromosome 17p and p53 Mutations in Human Endometrial Carcinoma of the Uterus
  • Human T-Lymphocytes Targeted against an Established Human Ovarian Carcinoma with a Bispecific F(ab′)2 Antibody Prolong Host Survival in a Murine Xenograft Model
Show more Basic Sciences

Articles

  • Down-regulation by Interleukin 4 of Activation of Human Alveolar Macrophages to the Tumoricidal State
  • Allelic Loss on Chromosome 17p and p53 Mutations in Human Endometrial Carcinoma of the Uterus
  • Human T-Lymphocytes Targeted against an Established Human Ovarian Carcinoma with a Bispecific F(ab′)2 Antibody Prolong Host Survival in a Murine Xenograft Model
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement